JAN 18, 2017 3:05 PM PST

Nightmare Superbug Kills US Woman

WRITTEN BY: Xuan Pham

Doctors and health experts have been warning the public about the rise of drug-resistant superbugs for the last year or so. Now, a 70-year-old woman from Nevada who succumbed to the disease is proof of how dire the situation really is.

During her travels to India, the woman suffered a break in her right leg. She then contracted an infection in her leg bones that eventually spread to her hip. When she returned to the US in August, her infection was severe. She eventually went into septic shock – a potentially lethal inflammatory reaction to infection involving the whole blood system. The woman passed away, showing no response to any antibiotic treatments.

Samples of her infections were confirmed by the Centers for Disease Control and Prevention (CDC) to be positive for the bacteria Klebsiella pneumonia. This bug is part of the family of bacteria that are extremely resistant to nearly all antibiotics, known as carbapenem-resistant Enterobacteriaceae (CRE). While this bug is normally found in the gut without any disturbance to the human host, the strain that led to the woman’s death was resistant to all 26 antibiotics. Even colistin, the “drug of last resort,” was no match for this superbug.

Although cases of superbug infections in the US have been reported, this case may be the first to have resulted in direct death of a patient. The CDC warned that more cases of “nightmare bacteria” may be on the horizon if we are not careful.

But what can we do? According to the World Health Organization (WHO), the first step in slowing antibiotic resistance starts with cutting down the unnecessary use of these drugs. Nearly 50 percent of antibiotics prescribed for respiratory infections may be unnecessary, as physicians can mistake viral infections for bacterial infections. Antibiotics should not be prescribed unless the infection is bacterial in nature and should respond to antibiotics. WHO also urges patients to follow the prescribed regimen, taking the full dose to completion, to prevent the growth of drug-resistant bacteria.

Other meaningful changes to slow antibiotic resistance may take place away from hospitals and patients. For example, farmers in the agricultural industries are also bear the burden of preventing livestock and crops from developing and spreading drug-resistant bacteria through appropriate use of antibiotics.

Meanwhile, the obvious question remains: Why don’t we make new antibiotics? The answer isn’t so simple since it’s been decades since the last new antibiotics were discovered. Finding new drugs for superbugs can take years for testing and approval, and this pipeline just hasn’t been in the forefront for most pharmaceutical companies recently.

"I think it’s concerning. We have relied for so long on just newer and newer antibiotics. But obviously the bugs can often [develop resistance] faster than we can make new ones," said Alexander Kallen, a CDC medical officer. However, it’s with great hope that cases such as this underscore our dire need for new drug developments.

Additional sources: BBC, Science Alert

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 04, 2019
Immunology
AUG 04, 2019
New Research In Reversing Deafness
Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate...
DEC 17, 2019
Immunology
DEC 17, 2019
Increased Belly Fat with Aging Linked to Reduced Mental Flexibility
Did you ever consider that your brain can flex similarly to the way your biceps can? Sure, brain flexing is more abstract and less literal, but the concept...
JAN 06, 2020
Genetics & Genomics
JAN 06, 2020
Some Genetic Sequencing Tests Are Coming Up Short
If it's suspected that a person has a genetic disease, doctors might send the patient's DNA for sequencing. But some sequencing tests may not be checking thoroughly....
FEB 24, 2020
Clinical & Molecular DX
FEB 24, 2020
Nanoparticles provide momentum for better diagnostic imaging
Photoacoustic imaging is an emerging tool with a vast array of biomedical applications ranging from the detection of brain lesions to imaging early signs o...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diag...
FEB 21, 2020
Clinical & Molecular DX
FEB 21, 2020
Diagnosing COVID-19
Diagnosing coronavirus is done through next-generation sequencing, real-time RT-PCR tests, cell culture, and electron miscopy. For patients, that translate...
Loading Comments...